MedTrace Logo

The Effects of Antihistamines on Pre-Pulse Inhibition

NCT01537471 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 117

Last updated 2013-01-16

No results posted yet for this study

Summary

The purpose of the investigators research is to test whether problems people have with processing their senses (feeling overwhelmed, distracted or upset by sounds and other stimuli) can be lessened by meclizine, a drug found in many over the counter antihistamines, which are medicines used for things like allergies, sleep problems, or the common cold.

Conditions

  • Healthy

Interventions

DRUG

Placebo

Placebo

DRUG

Meclizine

Meclizine 12.5 mg

DRUG

Meclizine

Meclizine 25 mg

Sponsors & Collaborators

  • Wallace H. Coulter Foundation

    collaborator OTHER

  • Duke University

    lead OTHER

Principal Investigators

  • Mark Z Rosenthal, PhD · Duke University

  • Ed Levin, MD · Duke University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2012-09-30
Completion
2012-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01537471 on ClinicalTrials.gov